1574 related articles for article (PubMed ID: 18087190)
1. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
2. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
3. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
Lee JE; Jang JY; Jeong SW; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY; Choi DL
World J Gastroenterol; 2012 Jun; 18(23):2979-87. PubMed ID: 22736922
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.
Sugiyama M; Sakahara H; Torizuka T; Kanno T; Nakamura F; Futatsubashi M; Nakamura S
J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15549449
[TBL] [Abstract][Full Text] [Related]
6. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY
Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
8. PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma.
Ho CL; Chen S; Cheng TK; Leung YL
Radiology; 2011 Feb; 258(2):515-23. PubMed ID: 21062922
[TBL] [Abstract][Full Text] [Related]
9. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
[TBL] [Abstract][Full Text] [Related]
10. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
Xia F; Wu L; Lau WY; Li G; Huan H; Qian C; Ma K; Bie P
PLoS One; 2014; 9(4):e95889. PubMed ID: 24760012
[TBL] [Abstract][Full Text] [Related]
11. Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.
Kawamura E; Shiomi S; Kotani K; Kawabe J; Hagihara A; Fujii H; Uchida-Kobayashi S; Iwai S; Morikawa H; Enomoto M; Murakami Y; Tamori A; Kawada N
J Gastroenterol Hepatol; 2014 Sep; 29(9):1722-7. PubMed ID: 24730671
[TBL] [Abstract][Full Text] [Related]
12. Extrahepatic metastases of hepatocellular carcinoma.
Katyal S; Oliver JH; Peterson MS; Ferris JV; Carr BS; Baron RL
Radiology; 2000 Sep; 216(3):698-703. PubMed ID: 10966697
[TBL] [Abstract][Full Text] [Related]
13. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
14. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
[TBL] [Abstract][Full Text] [Related]
16. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
[TBL] [Abstract][Full Text] [Related]
17. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.
Han AR; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Hepatogastroenterology; 2009; 56(93):1111-6. PubMed ID: 19760952
[TBL] [Abstract][Full Text] [Related]
18. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
19. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
[TBL] [Abstract][Full Text] [Related]
20. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
Chen YK; Hsieh DS; Liao CS; Bai CH; Su CT; Shen YY; Hsieh JF; Liao AC; Kao CH
Anticancer Res; 2005; 25(6C):4719-25. PubMed ID: 16334166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
